Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte Selects Chayon Laboratories as Exclusive Korean Distributor

Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Chayon Laboratories Inc. as its exclusive Korean distributor.

July 21, 2009

Sunnyvale, CA

Sunnyvale, CA — July 21, 2009 —Labcyte, the developer of acoustic liquid transfer, with systems in all of the top 10 pharmaceutical companies, today announced the selection of Chayon Laboratories Inc. as its exclusive Korean distributor.

“Chayon Laboratories will be a great partner for us in Korea,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Service of Labcyte Inc. “As we expand in Asia, Chayon will help us reach users in the growing genomics market. We feel that with the Labcyte platforms, Chayon can meet the genomics customers’ needs for miniaturization, precision and accuracy while remaining contamination-free. Chayon will also reach users in our established markets of pharmaceutical drug discovery, including compound management, high-throughput and secondary screening.

“We are very excited to be chosen by Labcyte as their partner in Korea,” said Mr. S. K. Kim, president of Chayon Laboratories. “We see a great potential market for low-volume transfer devices in Korea. We believe that the growing genomics markets, especially for gene expression, SNP analysis and RNAi, will find that the need for miniaturization is met particularly well by the Labcyte technologies. The superior advantages of the Labcyte products and our understanding of the potential user base in Korea sets up a situation where the customers will have optimal interactions with a local group while reaping the benefits of the best available technology.”

“As more people move to higher-density assays, the touchless liquid handling capabilities offered by the Labcyte acoustic products becomes essential,” said Nick Samaras, Managing Director, Asia-Pacific from his office in Melbourne. “In particular, our Echo® liquid handler provides better results, reduces costs by eliminating consumables and reduces toxic wastes. Our platform technology is also being applied in other fields such as array formation, the microencapsulation of compounds, particle production, proteomics research, the transfer of ultra-viscous materials, cell-based biology and imaging mass spectrometry.”

About Chayon Laboratories Inc.
Chayon Laboratories, Inc., founded in 1997, sells and supports a broad range of technologies to the Korean market for general biochemical and drug discovery research applications, including high throughput screening (HTS) and genomic analyses. Chayon Laboratories takes pride in their service and technical support. For more information, visit www.chayon.co.kr.

About Labcyte Inc.
Labcyte Inc. uses sound to move liquids. This green technology provides significantly better analytical results while saving money. The ‘touchless’ technology provides dramatically better answers by eliminating pipette tips and the adsorption of compounds during transfer, while saving hundreds of thousands of dollars in decreased consumables. Accuracy is maintained from first drop through last for a wide variety of fluids, including many considered intractable by other techniques. The technology is coupled with our Deerac™ instruments to make Labcyte a leader in liquid handling. Together with the Deerac systems, the award-winning Echo liquid handlers are used in all of the top 10 pharmaceutical companies, as well as in leading academic and research institutions worldwide. Labcyte technologies have broad applications including the fields of compound management, genomics, proteomics, particle manufacturing, encapsulation, imaging mass spectrometry, and live-cell transfer. Labcyte is headquartered in Sunnyvale, California with offices in Dublin, Ireland and has 39 U.S., 7 European and two Japanese patents and additional U.S. and international filings. For more information, visit www.labcyte.com.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP